Candriam Luxembourg S.C.A. raised its stake in Clorox Co (NYSE:CLX) by 5.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,549 shares of the company’s stock after acquiring an additional 630 shares during the quarter. Candriam Luxembourg S.C.A.’s holdings in Clorox were worth $1,737,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also modified their holdings of the company. Destination Wealth Management grew its position in shares of Clorox by 0.9% during the 3rd quarter. Destination Wealth Management now owns 40,063 shares of the company’s stock worth $6,026,000 after buying an additional 359 shares during the period. KCM Investment Advisors LLC grew its position in shares of Clorox by 0.3% during the 3rd quarter. KCM Investment Advisors LLC now owns 105,682 shares of the company’s stock worth $15,896,000 after buying an additional 363 shares during the period. Exeter Financial LLC grew its position in shares of Clorox by 3.9% during the 2nd quarter. Exeter Financial LLC now owns 9,719 shares of the company’s stock worth $1,314,000 after buying an additional 367 shares during the period. Oppenheimer Asset Management Inc. grew its position in shares of Clorox by 1.6% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 23,638 shares of the company’s stock worth $3,197,000 after buying an additional 383 shares during the period. Finally, Global X Management Co LLC grew its position in shares of Clorox by 6.0% during the 2nd quarter. Global X Management Co LLC now owns 6,899 shares of the company’s stock worth $933,000 after buying an additional 391 shares during the period. Institutional investors own 76.33% of the company’s stock.
Shares of CLX opened at $159.71 on Friday. The company has a debt-to-equity ratio of 3.38, a quick ratio of 0.65 and a current ratio of 1.07. Clorox Co has a twelve month low of $113.57 and a twelve month high of $163.44. The company has a market capitalization of $20.39 billion, a price-to-earnings ratio of 27.16, a P/E/G ratio of 3.92 and a beta of 0.28.
The business also recently declared a quarterly dividend, which will be paid on Friday, February 8th. Shareholders of record on Wednesday, January 23rd will be paid a $0.96 dividend. This represents a $3.84 dividend on an annualized basis and a yield of 2.40%. The ex-dividend date of this dividend is Tuesday, January 22nd. Clorox’s payout ratio is currently 61.34%.
In other Clorox news, SVP Diego J. Barral sold 12,880 shares of Clorox stock in a transaction that occurred on Tuesday, November 6th. The shares were sold at an average price of $157.98, for a total value of $2,034,782.40. Following the transaction, the senior vice president now owns 18,603 shares of the company’s stock, valued at $2,938,901.94. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Jon M. Balousek sold 3,354 shares of Clorox stock in a transaction that occurred on Wednesday, August 29th. The shares were sold at an average price of $144.73, for a total transaction of $485,424.42. The disclosure for this sale can be found here. In the last ninety days, insiders sold 93,970 shares of company stock worth $14,567,178. Insiders own 1.40% of the company’s stock.
Several equities research analysts have recently commented on CLX shares. Atlantic Securities began coverage on shares of Clorox in a research report on Thursday, September 20th. They set a “neutral” rating and a $151.00 price target for the company. Barclays set a $138.00 price objective on shares of Clorox and gave the stock a “hold” rating in a research note on Thursday, November 1st. Deutsche Bank lifted their price objective on shares of Clorox from $123.00 to $124.00 and gave the stock a “sell” rating in a research note on Thursday, November 1st. Wells Fargo & Co reissued a “hold” rating on shares of Clorox in a research note on Wednesday, October 31st. Finally, Citigroup lifted their price objective on shares of Clorox from $153.00 to $169.00 and gave the stock a “hold” rating in a research note on Tuesday. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $142.79.
ILLEGAL ACTIVITY NOTICE: “Candriam Luxembourg S.C.A. Boosts Holdings in Clorox Co (CLX)” was published by WKRB News and is the property of of WKRB News. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of U.S. & international copyright laws. The legal version of this piece of content can be viewed at https://www.wkrb13.com/2018/11/23/candriam-luxembourg-s-c-a-boosts-holdings-in-clorox-co-clx.html.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Recommended Story: What is the Rule of 72?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.